Revenue of $820.41M (+13.9% Y/Y) beats by $106.79M.
https://seekingalpha.com/news/3570914-endo-eps-beats-0_40-beats-on-revenueThursday, May 7, 2020
Novo Nordisk reports Q1 results
Novo Nordisk (NYSE:NVO): Q1 GAAP EPS of DKK5.05.
Revenue of DKK33.88B (+15.7% Y/Y)
Shares +2.05% PM.
https://seekingalpha.com/news/3570887-novo-nordisk-reports-q1-resultsBecton, Dickinson EPS beats by $0.26, beats on revenue
Becton, Dickinson (NYSE:BDX): Q2 Non-GAAP EPS of $2.55 beats by $0.26; GAAP EPS of $0.53 misses by $1.93.
Revenue of $4.25B (+1.2% Y/Y) beats by $150M.
https://seekingalpha.com/news/3570894-becton-dickinson-eps-beats-0_26-beats-on-revenueMednax EPS misses by $0.22, misses on revenue
Revenue of $845.92M (-0.6% Y/Y) misses by $4.96M.
https://seekingalpha.com/news/3570897-mednax-eps-misses-0_22-misses-on-revenueIntegra LifeSciences Holdings EPS misses by $0.15, beats on revenue
Integra LifeSciences Holdings (NASDAQ:IART): Q1 Non-GAAP EPS of $0.48 misses by $0.15; GAAP EPS of $0.11 misses by $0.09.
Revenue of $354.32M (-1.5% Y/Y) beats by $1.17M.
https://seekingalpha.com/news/3570902-integra-lifesciences-holdings-eps-misses-0_15-beats-on-revenueNovartis Gets FDA Accelerated Approval for Lung-Cancer Treatment, Diagnostic
Novartis AG said Thursday that the Food and Drug Administration has
approved its lung cancer treatment Tabrecta and the associated
diagnostic FoundationOne.
“This indication is approved under accelerated approval based on overall response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials,” the pharma giant said.
Tabrecta is a MET kinase inhibitor for adult patients with metastatic nonsmall cell lung cancer whose tumors have a mutation that leads to MET exon 14 skipping.
FoundationOne is a diagnostic that helps detecting mutations leading to MET exon 14 skipping in tumor tissue.
https://www.marketscreener.com/NOVARTIS-9364983/news/Novartis-Receives-FDA-Accelerated-Approval-for-Lung-Cancer-Treatment-Diagnostic-30555098/
“This indication is approved under accelerated approval based on overall response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials,” the pharma giant said.
Tabrecta is a MET kinase inhibitor for adult patients with metastatic nonsmall cell lung cancer whose tumors have a mutation that leads to MET exon 14 skipping.
FoundationOne is a diagnostic that helps detecting mutations leading to MET exon 14 skipping in tumor tissue.
https://www.marketscreener.com/NOVARTIS-9364983/news/Novartis-Receives-FDA-Accelerated-Approval-for-Lung-Cancer-Treatment-Diagnostic-30555098/
UnitedHealth to issue premium credits as part of $1.5 billion spending plan
U.S. health insurer UnitedHealth Group Inc said on Thursday it plans
to spend $1.5 billion on its customers in part by issuing credits
against some commercial health insurance premiums in June due to the new
coronavirus pandemic.
Insurers have gained financially as Americans have cut back on medical appointments under stay-at-home orders designed to help slow the spread of the virus and allow hospitals and doctors to focus on COVID-19 patients.
UnitedHealth said it would issue credits ranging from 5% to 20% of June monthly premiums to commercial fully-insured employer-based and individual insurance customers.
As part of its plan, UnitedHealth will also waive cost-sharing for specialist and primary physician visits in Medicare Advantage, the government healthcare program for people 65 and older or with disabilities that is managed by private insurers. UnitedHealth will stabilize premiums in its supplementary Medicare plans and expand Medicaid coverage. It has nearly 16 million members in these government plans.
UnitedHealth has 8.2 million members in at-risk insurance plans offered through employers and in individual plans created by the Affordable Care Act (ACA), also known as Obamacare. The rebates do not apply to its largest business in which it manages health benefits for large employers for a fee and the employer covers the medical costs.
Under the 2010 health law, fully insured health plans are required to spend no less than 80% of the premiums they collect on medical care or must send rebates to customers. But the process to determine rebates takes place over several years, Chief Executive Officer David Wichmann told reporters.
“As you know, people are hurting right now,” Wichmann said.
He said only a portion of the credits are related to the ACA requirement.
Wichmann said the company expected that deferred medical care would continue in the second quarter before returning in the second half of the year, an outlook he gave last month when announcing UnitedHealth’s first-quarter profit.
“Some of it obviously is permanently deferred,” he said, adding that was part of the reason for UnitedHealth’s $1.5 billion spending plan.
https://www.marketscreener.com/news/UnitedHealth-to-issue-premium-credits-as-part-of-1-5-billion-spending-plan–30556144/
Insurers have gained financially as Americans have cut back on medical appointments under stay-at-home orders designed to help slow the spread of the virus and allow hospitals and doctors to focus on COVID-19 patients.
UnitedHealth said it would issue credits ranging from 5% to 20% of June monthly premiums to commercial fully-insured employer-based and individual insurance customers.
As part of its plan, UnitedHealth will also waive cost-sharing for specialist and primary physician visits in Medicare Advantage, the government healthcare program for people 65 and older or with disabilities that is managed by private insurers. UnitedHealth will stabilize premiums in its supplementary Medicare plans and expand Medicaid coverage. It has nearly 16 million members in these government plans.
UnitedHealth has 8.2 million members in at-risk insurance plans offered through employers and in individual plans created by the Affordable Care Act (ACA), also known as Obamacare. The rebates do not apply to its largest business in which it manages health benefits for large employers for a fee and the employer covers the medical costs.
Under the 2010 health law, fully insured health plans are required to spend no less than 80% of the premiums they collect on medical care or must send rebates to customers. But the process to determine rebates takes place over several years, Chief Executive Officer David Wichmann told reporters.
“As you know, people are hurting right now,” Wichmann said.
He said only a portion of the credits are related to the ACA requirement.
Wichmann said the company expected that deferred medical care would continue in the second quarter before returning in the second half of the year, an outlook he gave last month when announcing UnitedHealth’s first-quarter profit.
“Some of it obviously is permanently deferred,” he said, adding that was part of the reason for UnitedHealth’s $1.5 billion spending plan.
https://www.marketscreener.com/news/UnitedHealth-to-issue-premium-credits-as-part-of-1-5-billion-spending-plan–30556144/
Subscribe to:
Comments (Atom)